Stuart Winkler
speaker
394 appearances
1 recordings
1 series
first heard Jul 2026
last heard 23 Jul
Stuart Winkler’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
Yeah, I think we
Like we think tighter is better, but that's not necessarily true.
I think that as surgeons we need like a Goldilocks approach, not too tight, not too loose, and that comes down to technique.
But back to the Coronas trial, I understand there was some long term follow up.
So what are your thoughts about the long term outcomes?
Right, right.
Or you could try monocryl.
I know that wasn't included in this study.
And I don't know that there's a trial that addresses the transfusion rates and molef monofilament versus braided multifilament on the uterus.
I think we take a trial like this.
I think we learned a lot from this trial, and I think we'd try to apply it as best we can.
All right, Howard, I'm ready to talk about a gynecology paper now.
Yeah.
So from these curatage specimens, they had 667 cases of atrophy, 77 cases of hormonal effect, 140 polyps, 114 endometrial cancers, and 112 cases of hyperplasia.
So actually, that's a lot of cancers and hyperplasia for the group.
So 1200 total, and almost 250 of them.
Who had cancer or hyperplasia.
When I do my counseling for patients, I usually, if I have a woman who comes to me with post-menopausal bleeding, just and no other incorporation of risk factors, I tell her that she has about a 10% risk of cancer, or at least I think that in my head.
But I do want to say, and you mentioned this with the saying that it was done in Nordic countries, these were most ex almost exclusively white patients, and that will be important in.
A minute when we talk about the recent changes.
Showing 241–260 of 394 · page 13 of 20
← Previous
Next →